Vireo Growth (VREOF) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Vireo Growth (VREOF) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Vireo Growth | 482.88 Mn | 340.58 Mn | 95.30 Mn | -94.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -86.79% |
| Dec 31, 2025 | 45.09% |
| Sep 30, 2025 | -99.42% |
| Jun 30, 2025 | -261.47% |
| Mar 31, 2025 | 10.60% |
| Dec 31, 2024 | -104.98% |
| Sep 30, 2024 | -29.49% |
| Jun 30, 2024 | 117.79% |
| Mar 31, 2024 | 15,392.90% |
| Dec 31, 2023 | 2,415.90% |
| Sep 30, 2023 | 2,285.50% |
| Jun 30, 2023 | -705.92% |
| Mar 31, 2023 | 100.71% |
| Dec 31, 2022 | 105.42% |
| Sep 30, 2022 | -110.72% |
| Jun 30, 2022 | 149.84% |
| Mar 31, 2022 | -243.81% |
| Dec 31, 2021 | -36.49% |
| Sep 30, 2021 | 99.11% |
| Jun 30, 2021 | 99.51% |